| Literature DB >> 30596086 |
Satoru Totsuka1, Tomoya Handa1,2, Hitoshi Ishikawa1,2, Nobuyuki Shoji1.
Abstract
We aimed to examine visual acuity improvement effect and adherence in amblyopia training using tablet type vision training equipment (Occlu-pad). The subjects were 138 patients with amblyopia (average age of 5.5 ± 1.6 years old); their amblyopic visual acuity at the start of training was logMAR 0.15 to 1.3. Occlu-pad is a device that processes images such that amblyopic eyes can only view the image as it passes through polarized glasses; this is achieved by peeling off the polarizing film layer in the liquid crystal display of an iPad (Apple). Amblyopia training comprised either the instructional training with Occlu-pad or the eye patch (Patching) as a family training, after wearing perfectly corrected glasses. Visual acuity improvement following amblyopia training by Occlu-pad and Patching was significantly different after 6 months in patients with anisometropic amblyopia (p <0.05). In patients with strabismic amblyopia, a significant difference between training methods was observed after 9 months (p <0.05). Use of the Occlu-pad resulted in better adherence for patients with either anisometropic amblyopia or strabismic amblyopia; a significant difference in adherence was observed after 3 months, compared with Patching (p <0.05). Amblyopia training with Occlu-pad supports greater visual acuity improvement and adherence than Patching.Entities:
Mesh:
Year: 2018 PMID: 30596086 PMCID: PMC6282136 DOI: 10.1155/2018/2394562
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patient characteristics.
| Occlu-pad | Patching | |
|---|---|---|
| Male | 36 (50) | 36 (55) |
| Female | 36 (50) | 30 (45) |
|
| ||
| Age at enrollment | ||
| 3 to < 5 years | 29 (40) | 24 (36) |
| 5 to 7 years | 25 (34) | 20 (30) |
| 7 to 9 years | 18 (25) | 22 (33) |
| Mean ± SD | 5.5 ± 1.7 | 5.0 ± 1.5 |
|
| ||
| Type of amblyopia | ||
| Anisometropia | 35 (48) | 35 (53) |
| Strabismus | 37 (51) | 31 (46) |
|
| ||
| Maximum magnitude of tropia | ||
| Deviation at distance measured by SPCT,Δ | ||
| Orthotropic | 42(58) | 34(52) |
| 1-9 | 12(17) | 14(21) |
| 10>= | 18(25) | 18(27) |
|
| ||
| Maximum magnitude of tropia | ||
| Deviation at near measured by SPCT,Δ | ||
| Orthotropic | 42(58) | 36(55) |
| 1-9 | 8(11) | 18(27) |
| 10>= | 22(31) | 12(18) |
|
| ||
| Distance visual acuity in amblyopic eye | (LogMAR) | |
| 1.3 to 1.0 | 22 (30) | 20 (30) |
| 0.8 to 0.4 | 30 (41) | 26 (39) |
| 0.3 to 0.15 | 20 (27) | 20 (30) |
| Mean ± SD | 4.5 ± 1.7 | 4.2 ± 1.2 |
|
| ||
| Distance visual acuity in fellow eye | (LogMAR) | |
| 0.1 to 0.0 | 4 (5) | 6 (9) |
| ≥ -0.1 | 68 (94) | 60 (90) |
| Mean ± SD | -0.05 ± 0.1 | -0.05 ± 0.1 |
|
| ||
| Refractive error in amblyopic eye (SE) | ||
| 0 to < +4.00D | 15 (20) | 12 (18) |
| +4.00D to < +7.00D | 41 (56) | 35 (53) |
| ≥ +7.00D | 16 (22) | 19 (28) |
| Mean ± SD (Diopter) | 5.5 ± 2.4 | 5.8 ± 1.6 |
|
| ||
| Refractive error in amblyopic eye | (Astigmatism) | |
| 0.00D to <0.50D | 21(29) | 21(32) |
| 0.50D to <1.00D | 15(21) | 10(15) |
| 1.00D to <1.50D | 16(22) | 18(27) |
| ≥1.50 | 20(28) | 17(26) |
| Mean ± SD(Diopter) | 1.0±0.9 | 1.2±1.0 |
|
| ||
| Refractive error in fellow eye (SE) | ||
| 0 to < +4.00D | 55(76) | 53(80) |
| +4.00D to < +7.00D | 11(15) | 7(11) |
| ≥ +7.00D | 6(8) | 6(9) |
| Mean(SD)D | 2.8±3.0 | 3.1±3.9 |
|
| ||
| Prior amblyopia treatment | ||
| None | 60(83) | 66(91) |
| Patching | 9(13) | 3(5) |
| Atropine | 0(0) | 2(3) |
| Patching and atropine | 3(4) | 1(1) |
Figure 1Occlu-pad [15].
Figure 2Best-corrected visual acuity (BCVA) for anisometropic amblyopia patients, from baseline to 3, 6, 9, and 12 months. Occlu-pad vs. Patching. BCVA significantly differed between Occlu-pad and Patching at 6, 9, and 12 months (∗p=0.02, ∗p=0.02, ∗p=0.03; ANOVA).
Figure 3Best-corrected visual acuity (BCVA) for strabismic amblyopia patients, from baseline to 3, 6, 9, and 12 months. Occlu-pad vs. Patching. BCVA significantly differed between Occlu-pad and Patching at 9 and 12 months (p=0.03, p=0.03; ANOVA).
Figure 4Changes in adherence over time. After 6 months, adherence fell 20% in the Patching group. All ∗P values were < 0.001 (Mann-Whitney U test).